1. Home
  2. OTLK vs BDMD Comparison

OTLK vs BDMD Comparison

Compare OTLK & BDMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OTLK
  • BDMD
  • Stock Information
  • Founded
  • OTLK 2010
  • BDMD 2012
  • Country
  • OTLK United States
  • BDMD China
  • Employees
  • OTLK N/A
  • BDMD N/A
  • Industry
  • OTLK Biotechnology: Biological Products (No Diagnostic Substances)
  • BDMD
  • Sector
  • OTLK Health Care
  • BDMD
  • Exchange
  • OTLK Nasdaq
  • BDMD NYSE
  • Market Cap
  • OTLK 121.8M
  • BDMD 106.4M
  • IPO Year
  • OTLK 2016
  • BDMD N/A
  • Fundamental
  • Price
  • OTLK $5.03
  • BDMD $2.40
  • Analyst Decision
  • OTLK Strong Buy
  • BDMD
  • Analyst Count
  • OTLK 7
  • BDMD 0
  • Target Price
  • OTLK $48.20
  • BDMD N/A
  • AVG Volume (30 Days)
  • OTLK 243.0K
  • BDMD 26.6K
  • Earning Date
  • OTLK 12-20-2024
  • BDMD 01-01-0001
  • Dividend Yield
  • OTLK N/A
  • BDMD N/A
  • EPS Growth
  • OTLK N/A
  • BDMD 578.78
  • EPS
  • OTLK N/A
  • BDMD 0.43
  • Revenue
  • OTLK N/A
  • BDMD $33,048,249.00
  • Revenue This Year
  • OTLK N/A
  • BDMD N/A
  • Revenue Next Year
  • OTLK N/A
  • BDMD N/A
  • P/E Ratio
  • OTLK N/A
  • BDMD $5.35
  • Revenue Growth
  • OTLK N/A
  • BDMD N/A
  • 52 Week Low
  • OTLK $4.61
  • BDMD $2.10
  • 52 Week High
  • OTLK $12.85
  • BDMD $13.52
  • Technical
  • Relative Strength Index (RSI)
  • OTLK 35.70
  • BDMD N/A
  • Support Level
  • OTLK $5.03
  • BDMD N/A
  • Resistance Level
  • OTLK $5.44
  • BDMD N/A
  • Average True Range (ATR)
  • OTLK 0.37
  • BDMD 0.00
  • MACD
  • OTLK -0.12
  • BDMD 0.00
  • Stochastic Oscillator
  • OTLK 2.01
  • BDMD 0.00

About OTLK Outlook Therapeutics Inc.

Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.

About BDMD BAIRD MEDICAL INVESTMENT HLDGS LTD

Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.

Share on Social Networks: